Logo image of CHSCN

CHS INC - CHSINC 7.1 PERP (CHSCN) Stock Fundamental Analysis

NASDAQ:CHSCN - Nasdaq - US12542R5063 - Currency: USD

25.2103  -0.04 (-0.16%)

Fundamental Rating

4

CHSCN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 89 industry peers in the Food Products industry. Both the profitability and the financial health of CHSCN get a neutral evaluation. Nothing too spectacular is happening here. CHSCN is valued expensive and it does not seem to be growing. Finally CHSCN also has an excellent dividend rating. This makes CHSCN very considerable for dividend investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

CHSCN had a positive operating cash flow in the past year.
CHSCN had positive earnings in each of the past 5 years.
Each year in the past 5 years CHSCN had a positive operating cash flow.
CHSCN Yearly Net Income VS EBIT VS OCF VS FCFCHSCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B 3B

1.2 Ratios

Looking at the Return On Assets, with a value of 7.92%, CHSCN belongs to the top of the industry, outperforming 84.27% of the companies in the same industry.
Looking at the Return On Equity, with a value of 14.11%, CHSCN is in the better half of the industry, outperforming 76.40% of the companies in the same industry.
CHSCN has a Return On Invested Capital (5.88%) which is comparable to the rest of the industry.
CHSCN had an Average Return On Invested Capital over the past 3 years of 5.40%. This is below the industry average of 9.00%.
The 3 year average ROIC (5.40%) for CHSCN is below the current ROIC(5.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROIC 5.88%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
CHSCN Yearly ROA, ROE, ROICCHSCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

CHSCN's Profit Margin of 3.62% is fine compared to the rest of the industry. CHSCN outperforms 60.67% of its industry peers.
In the last couple of years the Profit Margin of CHSCN has grown nicely.
CHSCN has a Operating Margin (2.42%) which is in line with its industry peers.
CHSCN's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 5.06%, CHSCN is doing worse than 84.27% of the companies in the same industry.
CHSCN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
CHSCN Yearly Profit, Operating, Gross MarginsCHSCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 1 2 3 4 5

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHSCN is creating some value.
CHSCN has a better debt/assets ratio than last year.
CHSCN Yearly Shares OutstandingCHSCN Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCN Yearly Total Debt VS Total AssetsCHSCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.82 indicates that CHSCN is not a great score, but indicates only limited risk for bankruptcy at the moment.
CHSCN's Altman-Z score of 2.82 is fine compared to the rest of the industry. CHSCN outperforms 62.92% of its industry peers.
The Debt to FCF ratio of CHSCN is 1.02, which is an excellent value as it means it would take CHSCN, only 1.02 years of fcf income to pay off all of its debts.
CHSCN has a Debt to FCF ratio of 1.02. This is amongst the best in the industry. CHSCN outperforms 88.76% of its industry peers.
CHSCN has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.19, CHSCN is doing good in the industry, outperforming 66.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Altman-Z 2.82
ROIC/WACC1.03
WACC5.73%
CHSCN Yearly LT Debt VS Equity VS FCFCHSCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.58 indicates that CHSCN should not have too much problems paying its short term obligations.
CHSCN has a Current ratio (1.58) which is comparable to the rest of the industry.
A Quick Ratio of 0.91 indicates that CHSCN may have some problems paying its short term obligations.
CHSCN has a Quick ratio of 0.91. This is comparable to the rest of the industry: CHSCN outperforms 51.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 0.91
CHSCN Yearly Current Assets VS Current LiabilitesCHSCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

More info and screens

1

3. Growth

3.1 Past

The Revenue for CHSCN has decreased by -17.09% in the past year. This is quite bad
CHSCN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.88% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCN Yearly Revenue VS EstimatesCHSCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 10B 20B 30B 40B

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCN Price Earnings VS Forward Price EarningsCHSCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHSCN is valued cheaper than 97.75% of the companies in the same industry.
98.88% of the companies in the same industry are more expensive than CHSCN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.14
EV/EBITDA 0.96
CHSCN Per share dataCHSCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1K 2K 3K

4.3 Compensation for Growth

The decent profitability rating of CHSCN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

8

5. Dividend

5.1 Amount

CHSCN has a Yearly Dividend Yield of 7.36%, which is a nice return.
Compared to an average industry Dividend Yield of 4.44, CHSCN pays a better dividend. On top of this CHSCN pays more dividend than 93.26% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.44, CHSCN pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.36%

5.2 History

CHSCN has paid a dividend for at least 10 years, which is a reliable track record.
CHSCN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years10
CHSCN Yearly Dividends per shareCHSCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

11.11% of the earnings are spent on dividend by CHSCN. This is a low number and sustainable payout ratio.
DP11.11%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCN Yearly Income VS Free CF VS DividendCHSCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B
CHSCN Dividend Payout.CHSCN Dividend Payout, showing the Payout Ratio.CHSCN Dividend Payout.PayoutRetained Earnings

More info and screens

CHS INC - CHSINC 7.1 PERP

NASDAQ:CHSCN (5/2/2025, 8:00:00 PM)

25.2103

-0.04 (-0.16%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-01 2025-04-01
Earnings (Next)07-08 2025-07-08
Inst Owners13.41%
Inst Owner Change0%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap309.33M
Analysts0
Price TargetN/A
Short Float %0.06%
Short Ratio0.38
Dividend
Industry RankSector Rank
Dividend Yield 7.36%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP11.11%
Div Incr Years0
Div Non Decr Years10
Ex-Date06-13 2025-06-13 (0.44375)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.14
P/OCF 0.11
P/B 0.03
P/tB 0.03
EV/EBITDA 0.96
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)178.98
FCFY709.95%
OCF(TTM)233.94
OCFY927.94%
SpS3422.59
BVpS877.08
TBVpS877.08
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.92%
ROE 14.11%
ROCE 7.68%
ROIC 5.88%
ROICexc 6.17%
ROICexgc 6.17%
OM 2.42%
PM (TTM) 3.62%
GM 5.06%
FCFM 5.23%
ROA(3y)7.36%
ROA(5y)5.96%
ROE(3y)14.03%
ROE(5y)11.3%
ROIC(3y)5.4%
ROIC(5y)4.37%
ROICexc(3y)5.96%
ROICexc(5y)4.73%
ROICexgc(3y)6.08%
ROICexgc(5y)4.81%
ROCE(3y)7.21%
ROCE(5y)6.02%
ROICexcg growth 3Y73.02%
ROICexcg growth 5Y27.66%
ROICexc growth 3Y72.21%
ROICexc growth 5Y27.52%
OM growth 3Y44.42%
OM growth 5Y18.46%
PM growth 3Y41.04%
PM growth 5Y11.91%
GM growth 3Y14.66%
GM growth 5Y9.3%
F-Score6
Asset Turnover2.19
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 1.02
Debt/EBITDA 1.33
Cap/Depr 122.19%
Cap/Sales 1.61%
Interest Coverage 250
Cash Conversion 182.9%
Profit Quality 144.65%
Current Ratio 1.58
Quick Ratio 0.91
Altman-Z 2.82
F-Score6
WACC5.73%
ROIC/WACC1.03
Cap/Depr(3y)76.68%
Cap/Depr(5y)79.95%
Cap/Sales(3y)0.94%
Cap/Sales(5y)1.13%
Profit Quality(3y)105.8%
Profit Quality(5y)111.96%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.09%
Revenue growth 3Y17.08%
Revenue growth 5Y6.88%
Sales Q2Q%-19.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-35.39%
EBIT growth 3Y69.09%
EBIT growth 5Y26.62%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y620.74%
FCF growth 3Y59.62%
FCF growth 5Y30.48%
OCF growth 1Y387.5%
OCF growth 3Y44.56%
OCF growth 5Y25.04%